Sartorius, a global life science company, agreed to invest $46m in BICO, a provider of life science solutions and laboratory automation. “The strategic collaboration with Sartorius is expected to significantly expand our presence and accelerate growth in Asia-Pacific, where BICO today has considerable expansion potential. BICO will get access to value adding, complementary technologies and products, which will enhance our current customer offering within bioprinting and lab automation. We consider the Sartorius ownership in BICO as a verification of the BICO growth strategy,” Erik Gatenholm, BICO CEO and Co-Founder.